ArticleJournal of the Chinese Medical Association : JCMA2019

Daclatasvir plus sofosbuvir, with or without ribavirin, is highly effective for all kinds of genotype-2 chronic hepatitis-C infection in Taiwan.

Sih-Hsien Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.